Private Label Multi-Active Scalp Foam – Professional Scalp Care

Finasteride 0.03%; Minoxidil 7.5%; Tretinoin 0.0125%; Ketoconazole 2%; Latanoprost 0.003%; Biotin; Enhanced Vitamin Complex; Peptides. The final quantitative formula, excipients, compatibility, stability and analytical specification must be confirmed by the responsible licensed manufacturer or compounder.

Professional assessment and patient-specific prescribing or dispensing controls may be required. Final labeling must include all applicable contraindications, pregnancy-related precautions, adverse effects, transfer risks, storage conditions, directions and emergency information. Do not infer safety or suitability from topical use alone.

For qualified businesses only. Provide your destination market, intended regulatory pathway, licensed manufacturing or compounding arrangement, target quantity and packaging requirements. Any project is subject to formula feasibility, stability, quality, legal and regulatory review before quotation or production.